45 LIBERTY BLVD., MALVERN, PA
News
Galera Therapeutics Implements 1-for-200 Reverse Stock Split
Other Events
Stock Increase and Written Consent Amendments Approved by Stockholders
Director Elections and Say-on-Pay Approval at Galera Therapeutics
Annual Report to Security Holders
Announce Merger Agreement and $350 Million Concurrent Private Placement, Investor Presentation
Q1
FY 2025
Q3
Q2
FY 2024
Notice of Late Filing for Quarterly Report
Effectiveness Notice
Notice of Suspension of Duty to File Reports
Prospectus Filed Pursuant to Rule 425
Definitive Additional Proxy Soliciting Materials
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
S-8 POS
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload